Altrova HealthFRA:WF8 EV-to-FCF is -7.92 as of Jun. 27, 2026. The stock has 3 warning signs investors should review. Among 938 Asset Management companies, Altrova Health ranks worse than 106609.7% on this metric.
EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, Altrova Health's Enterprise Value is €5.57 Mil.
Altrova Health's Free Cash Flow for the trailing twelve months (TTM) ended in Mar. 2026 was €-0.70 Mil. Therefore, Altrova Health's EV-to-FCF for today is -7.92.
The historical rank and industry rank for Altrova Health's EV-to-FCF or its related term are showing as below:
FRA:WF8'
s EV-to-FCF Range Over the Past 10 Years
Min: -15.65 Med: -10.77 Max: -8.54
Current: -8.83
During the past 3 years, the highest EV-to-FCF of Altrova Health was -8.54. The lowest was -15.65. And the median was -10.77.
FRA:WF8's EV-to-FCF is ranked worse than 100% of 938
companies
in the Asset Management industry
Industry Median: 14.545
vs FRA:WF8: -8.83
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Altrova Health's PE Ratio (TTM) for today is calculated as:
Altrova Health's share price for today is €0.0244.
Altrova Health's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was €-0.013.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.
Altrova Health EV-to-FCF Related Terms
Altrova Health EV-to-FCF Historical Data
* Premium members only.
The historical data trend for Altrova Health's EV-to-FCF can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Asset Management subindustry, Altrova Health's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Altrova Health EV-to-FCF vs Asset Management Industry
For the Asset Management industry and Financial Services sector, Altrova Health's EV-to-FCF distribution charts can be found below:
* The bar in red indicates where Altrova Health's EV-to-FCF falls into.
Altrova Health's current Enterprise Value is €5.57 Mil.
Altrova Health's Free Cash Flow for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was €-0.70 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Altrova Health (FRA:WF8) has a EV-to-FCF of -7.92 as of Jun. 27, 2026. EV to FCF ratio is the company's enterprise value divided by free cash flow. View historical data on Altrova Health and its competitors. According to the industry distribution chart, Altrova Health ranks #999999 out of 938 companies in the Asset Management industry.
Is Altrova Health's EV-to-FCF too high?
Altrova Health's current EV-to-FCF is -7.92. Based on the distribution chart, Altrova Health ranks #999999 out of 938 companies in the Asset Management industry, which is in the bottom quartile relative to peers.
How does Altrova Health's EV-to-FCF compare to BLK and BX?
According to the Asset Management industry distribution chart, Altrova Health ranks #999999 out of 938 companies for EV-to-FCF. This places Altrova Health in the lower half of its industry. The industry median EV-to-FCF is 14.55. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-FCF for an Asset Management company?
The median EV-to-FCF among Asset Management companies is 14.55, based on 938 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-FCF significantly above this median, while those in the bottom quartile fall well below. However, EV-to-FCF should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-FCF mean?
A high EV-to-FCF can signal that a stock is expensive relative to its fundamentals. EV to FCF ratio is the company's enterprise value divided by free cash flow. View historical data on Altrova Health and its competitors. For the Asset Management industry, the median EV-to-FCF is 14.55 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Altrova Health's current EV-to-FCF is -7.92. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Altrova Health stock overvalued right now?
Altrova Health (FRA:WF8) has a current EV-to-FCF of -7.92. The current EV-to-FCF is -7.92. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-FCF calculated?
EV-to-FCF is calculated from a company's financial statements. For Altrova Health (FRA:WF8), the current EV-to-FCF is -7.92 as of Jun. 27, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Altrova Health Inc is a Canadian public company building a growing portfolio of health solutions across detection, protection, treatment, and wellness. The Company is focused on supporting multiple products, brands, and growth pathways under one stronger corporate identity, expanding beyond any single product story to create a more durable business. The Company continues to evaluate opportunities to expand its product offerings across the public health and safety sector.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:WF8 has been successfully added to your 